Evidence map›Paper›PMID 35058472›Full record

ArticleNature communications2022

Accurate determination of solvation free energies of neutral organic compounds from first principles.

Leonid Pereyaslavets, Ganesh Kamath, Oleg Butin, Alexey Illarionov, Michael Olevanov, Igor Kurnikov, Serzhan Sakipov, Igor Leontyev, Ekaterina Voronina, Tyler Gannon and 15 more

Abstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The Q-AMOEBA (CF) Polarizable Potential.The journal of physical chemistry letters · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Leonid Pereyaslavets *InterX Inc, 805 Allston Way, Berkeley, CA, 94710, USA. leonid.pereyaslavets@interxinc.com.
Ganesh Kamath *InterX Inc, 805 Allston Way, Berkeley, CA, 94710, USA.
Oleg ButinInterX Inc, 805 Allston Way, Berkeley, CA, 94710, USA.
Alexey IllarionovInterX Inc, 805 Allston Way, Berkeley, CA, 94710, USA.
Michael OlevanovInterX Inc, 805 Allston Way, Berkeley, CA, 94710, USA.
Igor KurnikovInterX Inc, 805 Allston Way, Berkeley, CA, 94710, USA.
Serzhan SakipovInterX Inc, 805 Allston Way, Berkeley, CA, 94710, USA.ORCID 0000-0001-7414-4670
Igor LeontyevInterX Inc, 805 Allston Way, Berkeley, CA, 94710, USA.
Ekaterina VoroninaInterX Inc, 805 Allston Way, Berkeley, CA, 94710, USA.
Tyler GannonInterX Inc, 805 Allston Way, Berkeley, CA, 94710, USA.
Grzegorz NawrockiInterX Inc, 805 Allston Way, Berkeley, CA, 94710, USA.
Mikhail DarkhovskiyInterX Inc, 805 Allston Way, Berkeley, CA, 94710, USA.ORCID 0000-0003-3682-5568
Ilya IvahnenkoInterX Inc, 805 Allston Way, Berkeley, CA, 94710, USA.
Alexander KostikovInterX Inc, 805 Allston Way, Berkeley, CA, 94710, USA.
Jessica ScarantoDepartment of Chemistry, Carnegie Mellon University, Pittsburgh, PA, 15213, USA.
Maria G KurnikovaDepartment of Chemistry, Carnegie Mellon University, Pittsburgh, PA, 15213, USA.ORCID 0000-0002-8010-8374
Suvo BanikCenter for Nanoscale Materials, Argonne National Lab, Argonne, IL, 60439, USA.ORCID 0000-0001-7239-8853
Henry ChanCenter for Nanoscale Materials, Argonne National Lab, Argonne, IL, 60439, USA.ORCID 0000-0002-8198-7737
Michael G SternbergCenter for Nanoscale Materials, Argonne National Lab, Argonne, IL, 60439, USA.
Subramanian K R S SankaranarayananCenter for Nanoscale Materials, Argonne National Lab, Argonne, IL, 60439, USA.ORCID 0000-0002-9708-396X
Brad CrawfordDepartment of Chemical Engineering and Materials Science, Wayne State University, Detroit, MI, 48202, USA.ORCID 0000-0003-0638-7333
Jeffrey PotoffDepartment of Chemical Engineering and Materials Science, Wayne State University, Detroit, MI, 48202, USA.
Michael LevittDepartment of Structural Biology, Stanford University School of Medicine, Stanford, CA, 94304, USA.
Roger D KornbergDepartment of Structural Biology, Stanford University School of Medicine, Stanford, CA, 94304, USA.
Boris Fain *InterX Inc, 805 Allston Way, Berkeley, CA, 94710, USA. boris.fain@interxinc.com.

Funding

Emergent Properties of Complex Systems: From Atoms to Macromolecules; from Humans to SocietiesR35GM122543 · NIGMS · STANFORD UNIVERSITY · PI MICHAEL LEVITT · 2017 to 2026
$5.1M
6 · The paper itself

Abstract

The main goal of molecular simulation is to accurately predict experimental observables of molecular systems. Another long-standing goal is to devise models for arbitrary neutral organic molecules with little or no reliance on experimental data. While separately these goals have been met to various degrees, for an arbitrary system of molecules they have not been achieved simultaneously. For biophysical ensembles that exist at room temperature and pressure, and where the entropic contributions are on par with interaction strengths, it is the free energies that are both most important and most difficult to predict. We compute the free energies of solvation for a diverse set of neutral organic compounds using a polarizable force field fitted entirely to ab initio calculations. The mean absolute errors (MAE) of hydration, cyclohexane solvation, and corresponding partition coefficients are 0.2 kcal/mol, 0.3 kcal/mol and 0.22 log units, i.e. within chemical accuracy. The model (ARROW FF) is multipolar, polarizable, and its accompanying simulation stack includes nuclear quantum effects (NQE). The simulation tools' computational efficiency is on a par with current state-of-the-art packages. The construction of a wide-coverage molecular modelling toolset from first principles, together with its excellent predictive ability in the liquid phase is a major advance in biomolecular simulation.

Identifiers

PMID35058472
PMCPMC8776904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.